ArticleEpilepsia open2026
Fast ripple-delta coupling as an early biomarker for post-traumatic epileptogenesis in repetitive brain injury.
Article in Epilepsia open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Individualized and stereotypical seizure semiology in a porcine model of post-traumatic epilepsy.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
objectiveTraumatic brain injury (TBI) can induce posttraumatic epilepsy (PTE), but early biomarkers for epileptogenesis are lacking. We aimed to investigate electrographic biomarkers before and during posttraumatic seizure development.
methodsWe used a repetitive diffuse TBI model in mice with continuous video-EEG monitoring up to 4½ months postinjury.
resultsTwenty-five percent of mice developed posttraumatic seizures (PTS) with highly variable latency (5-126 days postinjury). Most significantly, we identified fast ripple-delta DOWN state coupling as an early biomarker that was detectable at 4 days post-TBI and appeared before seizure onset in all seizure-experiencing mice. This EEG signature distinguished seizure-experiencing from seizure-free TBI mice with high specificity. Power spectrum analysis revealed elevated delta and theta power, reduced physiological fast oscillations (alpha, beta, gamma), and increased pathological high-frequency oscillations (fast ripples) in seizure-experiencing animals, indicating network hyperexcitability. Spike analysis showed that while TBI itself increased cortical excitability, seizure onset triggered a dramatic further interictal activity escalation. These electrographic signatures were remarkably consistent across all seizure-experiencing animals regardless of single or recurrent seizure pattern. SIGNIFICANCE: Our results demonstrate that fast ripple-delta coupling represents a promising early biomarker detectable at 4 days post-TBI, before seizure onset, offering potential for early identification of PTS susceptibility. Importantly, this biomarker identified all seizure-prone animals regardless of whether they developed single or recurrent seizures, suggesting shared underlying mechanisms and clinical relevance for any PTS occurrence. These findings emphasize the utility of temporal EEG analysis for detecting early electrographic changes in posttraumatic epileptogenesis and may inform future intervention strategies. PLAIN LANGUAGE SUMMARY: Some people develop epilepsy after a traumatic brain injury, but it is currently impossible to predict who is at risk. Using mice, we found that a specific brain wave pattern, brief bursts of very fast electrical activity occurring during deep sleep, appeared within days after injury in animals that later developed seizures. This pattern was not seen in injured animals that remained seizure-free. Detecting this early warning sign could help identify at-risk individuals and enable earlier treatment to potentially prevent epilepsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.